Cargando…
P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429651/ http://dx.doi.org/10.1097/01.HS9.0000848860.58516.71 |
| _version_ | 1784779522708602880 |
|---|---|
| author | van Dijk, M. J. Rab, M. A. van Oirschot, B. A. Bos, J. Derichs, C. Rijneveld, A. W. Cnossen, M. H. Nur, E. Biemond, B. J. Bartels, M. Jans, J. J. van Solinge, W. W. Schutgens, R. E. van Wijk, R. van Beers, E. J. |
| author_facet | van Dijk, M. J. Rab, M. A. van Oirschot, B. A. Bos, J. Derichs, C. Rijneveld, A. W. Cnossen, M. H. Nur, E. Biemond, B. J. Bartels, M. Jans, J. J. van Solinge, W. W. Schutgens, R. E. van Wijk, R. van Beers, E. J. |
| author_sort | van Dijk, M. J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429651 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94296512022-08-31 P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE van Dijk, M. J. Rab, M. A. van Oirschot, B. A. Bos, J. Derichs, C. Rijneveld, A. W. Cnossen, M. H. Nur, E. Biemond, B. J. Bartels, M. Jans, J. J. van Solinge, W. W. Schutgens, R. E. van Wijk, R. van Beers, E. J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429651/ http://dx.doi.org/10.1097/01.HS9.0000848860.58516.71 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters van Dijk, M. J. Rab, M. A. van Oirschot, B. A. Bos, J. Derichs, C. Rijneveld, A. W. Cnossen, M. H. Nur, E. Biemond, B. J. Bartels, M. Jans, J. J. van Solinge, W. W. Schutgens, R. E. van Wijk, R. van Beers, E. J. P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title | P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title_full | P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title_fullStr | P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title_full_unstemmed | P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title_short | P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE |
| title_sort | p1501: follow-up results of a phase 2 study assessing the safety and efficacy of mitapivat treatment, an oral pyruvate kinase activator, for up to 60 weeks in subjects with sickle cell disease |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429651/ http://dx.doi.org/10.1097/01.HS9.0000848860.58516.71 |
| work_keys_str_mv | AT vandijkmj p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT rabma p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT vanoirschotba p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT bosj p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT derichsc p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT rijneveldaw p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT cnossenmh p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT nure p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT biemondbj p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT bartelsm p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT jansjj p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT vansolingeww p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT schutgensre p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT vanwijkr p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease AT vanbeersej p1501followupresultsofaphase2studyassessingthesafetyandefficacyofmitapivattreatmentanoralpyruvatekinaseactivatorforupto60weeksinsubjectswithsicklecelldisease |